Wearable sensors and blood markers may predict delirium in intensive care

NCT ID NCT07694206

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study investigates whether digital biometrics and blood-based markers can help detect, predict, and track delirium in older adults admitted to the intensive care unit (ICU). Participants wear a digital device to collect data like activity and heart rate, and provide blood samples during their ICU stay. Researchers also assess delirium daily using a standard tool. The goal is to find new ways to identify delirium earlier and improve care for critically ill older patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to better ways to detect and predict delirium in ICU patients, potentially improving outcomes and reducing complications.
What could go wrong
This is an observational study, not a treatment trial. It may not identify reliable biomarkers, and findings may not apply to all ICU patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness delirium insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Scripps Green Hospital

    NOT_YET_RECRUITING

    La Jolla, California, 92037, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Scripps Memorial La Jolla Hospital

    RECRUITING

    San Diego, California, 92117, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.